The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022
Name:
37263081.pdf
Size:
442.2Kb
Format:
PDF
Description:
Identified with Open Access button
Authors
Ducreux, M.Abou-Alfa, G. K.
Bekaii-Saab, T.
Berlin, J.
Cervantes, A.
de Baere, T.
Eng, C.
Galle, P.
Gill, S.
Gruenberger, T.
Haustermans, K.
Lamarca, Angela
Laurent-Puig, P.
Llovet, J. M.
Lordick, F.
Macarulla, T.
Mukherji, D.
Muro, K.
Obermannova, R.
O'Connor, J. M.
O'Reilly, E. M.
Osterlund, P.
Philip, P.
Prager, G.
Ruiz-Garcia, E.
Sangro, B.
Seufferlein, T.
Tabernero, J.
Verslype, C.
Wasan, H.
Van Cutsem, E.
Affiliation
Université Paris-Saclay, Gustave Roussy, Villejuif, France.Issue Date
2023
Metadata
Show full item recordAbstract
This article summarises expert discussion on the management of patients with hepatocellular carcinoma (HCC), which took place during the 24th World Gastrointestinal Cancer Congress (WGICC) in Barcelona, July 2022. A multidisciplinary approach is mandatory to ensure an optimal diagnosis and staging of HCC, planning of curative and therapeutic options, including surgical, embolisation, ablative strategies, or systemic therapy. Furthermore, in many patients with HCC, underlying liver cirrhosis represents a challenge and influences the therapeutic options.Citation
Ducreux M, Abou-Alfa GK, Bekaii-Saab T, Berlin J, Cervantes A, de Baere T, et al. The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022. ESMO open. 2023 May 30;8(3):101567. PubMed PMID: 37263081. Pubmed Central PMCID: PMC10245111. Epub 2023/06/02. eng.Journal
ESMO OpenDOI
10.1016/j.esmoop.2023.101567PubMed ID
37263081Additional Links
https://dx.doi.org/10.1016/j.esmoop.2023.101567Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.esmoop.2023.101567
Scopus Count
Collections
Related articles
- Australian recommendations for the management of hepatocellular carcinoma: a consensus statement.
- Authors: Lubel JS, Roberts SK, Strasser SI, Thompson AJ, Philip J, Goodwin M, Clarke S, Crawford DH, Levy MT, Shackel N
- Issue date: 2021 Jun
- Qualitative evidence synthesis informing our understanding of people's perceptions and experiences of targeted digital communication.
- Authors: Ryan R, Hill S
- Issue date: 2019 Oct 23
- Depressing time: Waiting, melancholia, and the psychoanalytic practice of care.
- Authors: Kirtsoglou E, Simpson B, Salisbury L, Baraitser L
- Issue date: 2020
- Pivoting to telemedicine in a single-day multidisciplinary liver tumor clinic during COVID-19: the Texas Liver Tumor Center experience.
- Authors: Crow KS, Poordad FF, Halff GA, Cigarroa FG, Tsai E, Infante IV, Arora SP
- Issue date: 2023 Nov
- Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
- Authors: Lee CC, Chen CW, Yen HK, Lin YP, Lai CY, Wang JL, Groot OQ, Janssen SJ, Schwab JH, Hsu FM, Lin WH
- Issue date: 2024 Dec 1